Nagy Z, Vastag M, Skopál J, Kolev K, Machovich R, Krámer J, Karádi I, Tóth M
National Stroke Centre, Budapest, Hungary.
Keio J Med. 1996 Sep;45(3):200-6. doi: 10.2302/kjm.45.200.
Cerebral ischemia is caused by reduced blood supply at the microcirculatory level. In the microvessels, the main elements of the reperfusion injury following brain ischemia are the transformation of endothelial cell-surface from anticoagulant to procoagulant property, leukocyte adhesion, sludge or clot formation. There is a paucity of information on how hemostatic factors, cytokines, lipoprotein(a) (Lp(a)) and endothelin-1 (ET-1), being responsible for ischemic/reperfusion injury, interact with human brain microvessel endothelium (HBEC). There are no data furthermore about the expression of complement proteins of HBEC influenced by cytokines or fibrinolytic factors. Previously we established optimal conditions for culturing HBEC. Cell contraction induced by thrombin, plasmin, miniplasmin was recorded. The reassembly of F-actin was observed after thrombin treatment. ICAM-1 upregulation was measured following TNF-alpha, IL-1-alpha and thrombin incubation. Plasmin and miniplasmin downregulated the ICAM-1 in our cell culture system. Lp(a) modulated the thromboresistant cell-surface by reduction of t-PA and u-PA, but PAI-1 remained unchanged. Lp(a) modulated the ET-1 production by early increasing and late decreasing, in a bimodal manner. The increased secretion of ET-1 by cytokines (TNF-alpha, IL-1-alpha) was reduced in the presence of Lp(a). Gradual increase of complement proteins (factor H, factor B, C4) was induced by cytokines. Plasmin and miniplasmin augmented a rapid increase of C4. Some factors of complex relationship between regulators and modulators of endothelial adhesion molecules have been demonstrated in a human cell culture system prepared from brain microvessel endothelium. A unified concept of sequential events of ischemia/reperfusion in the brain has not yet developed.
脑缺血是由微循环水平的血液供应减少引起的。在微血管中,脑缺血后再灌注损伤的主要因素是内皮细胞表面从抗凝特性转变为促凝特性、白细胞粘附、血液淤滞或血栓形成。关于负责缺血/再灌注损伤的止血因子、细胞因子、脂蛋白(a) [Lp(a)] 和内皮素-1 (ET-1) 如何与人脑微血管内皮细胞 (HBEC) 相互作用的信息很少。此外,没有关于细胞因子或纤溶因子影响下的HBEC补体蛋白表达的数据。此前我们建立了培养HBEC的最佳条件。记录了凝血酶、纤溶酶、微型纤溶酶诱导的细胞收缩。观察了凝血酶处理后F-肌动蛋白的重新组装。在肿瘤坏死因子-α、白细胞介素-1-α和凝血酶孵育后测量细胞间粘附分子-1 (ICAM-1) 的上调。在我们的细胞培养系统中,纤溶酶和微型纤溶酶下调了ICAM-1。Lp(a) 通过降低组织型纤溶酶原激活剂 (t-PA) 和尿激酶型纤溶酶原激活剂 (u-PA) 来调节抗血栓细胞表面,但纤溶酶原激活物抑制剂-1 (PAI-1) 保持不变。Lp(a) 以双峰方式通过早期增加和晚期减少来调节ET-1的产生。在Lp(a) 存在的情况下,细胞因子 (肿瘤坏死因子-α、白细胞介素-1-α) 诱导的ET-1分泌增加减少。细胞因子诱导补体蛋白 (H因子、B因子、C4) 逐渐增加。纤溶酶和微型纤溶酶增强了C4的快速增加。在由脑微血管内皮细胞制备的人类细胞培养系统中,已经证明了内皮粘附分子调节剂和调节物之间复杂关系的一些因素。尚未形成关于脑缺血/再灌注连续事件的统一概念。